Last reviewed · How we verify
NCT02598492
Imputation of PaO2 From SaO2
trial testing arterial blood gas in Acute Respiratory Failure in 646 participants. Completed in 31 December 2020.
30 June 2020
Quick facts
| Lead sponsor | Brigham and Women's Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 646 |
| Start date | 1 September 2015 |
| Primary completion | 30 June 2020 |
| Estimated completion | 31 December 2020 |
| Sites | 3 locations across China, United States |
Drugs / interventions tested
- arterial blood gas — full drug profile →
Conditions studied
- Acute Respiratory Failure — all drugs for Acute Respiratory Failure →
Sponsor
Brigham and Women's Hospital
Who can join
18 and older, any sex, with Acute Respiratory Failure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aims of this study are (1) to find out the relationship between PaO2 and SaO2 among mechanically ventilated patients and (2) to create a reliable system to utilize SF ratios to impute the PF ratios in assessing the respiratory parameter of the SOFA score.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT02598492
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of arterial blood gas
Trials testing the same drug.
- NCT04354220 — Capnography Monitoring in Ventilated Children · unknown
Other recruiting trials for Acute Respiratory Failure
Currently open trials in the same condition.
- NCT06189924 — Exhaled Breath Condensate Analysis in Mechanically Ventilated Patients · recruiting
- NCT06912360 — Continous Positive Airway Pressure (CPAP) Support for Acute Hypoxemic Respiratory Failure in Burkina Faso · NA · recruiting
- NCT06876168 — Virtual Reality in ICU - PARTNER · recruiting
- NCT06952816 — Validation Study of the EMILY AI Device in Acute and Chronic Respiratory Failure · NA · recruiting
- NCT06934876 — Waveform Capnography Compared to Colorimetric Carbon Dioxide Detection During Tracheal Intubation of Critically Ill Adul · recruiting
Other Brigham and Women's Hospital trials
Trials by the same sponsor.
- NCT07011758 — Dynamic Treatment Regimes for Opioid Use Disorder · Phase 2 · not yet recruiting
- NCT06310018 — Augmented Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for PE · suspended
- NCT04519177 — Randomized Trial of a Sleep Disorders Program on Firefighter Safety and Disability ... · NA · not yet recruiting
- NCT06355986 — Computerized Decision Support to Prevent Stroke in Atrial Fibrillation · NA · not yet recruiting
- NCT06099275 — Evaluation of Hemodynamics in People With Untreated Preeclampsia Using Echocardiography · suspended
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02598492 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Brigham and Women's Hospital
- Last refreshed: 8 March 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02598492.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing